HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial uncoupler exerts a synthetic lethal effect against β-catenin mutant tumor cells.

Abstract
The wingless/int-1 (Wnt) signal transduction pathway plays a central role in cell proliferation, survival, differentiation and apoptosis. When β-catenin: a component of the Wnt pathway, is mutated into an active form, cell growth signaling is hyperactive and drives oncogenesis. As β-catenin is mutated in a wide variety of tumors, including up to 10% of all sporadic colon carcinomas and 20% of hepatocellular carcinomas, it has been considered a promising target for therapeutic interventions. Therefore, we screened an in-house natural product library for compounds that exhibited synthetic lethality towards β-catenin mutations and isolated nonactin, an antibiotic mitochondrial uncoupler, as a hit compound. Nonactin, as well as other mitochondrial uncouplers, induced apoptosis selectively in β-catenin mutated tumor cells. Significant tumor regression was observed in the β-catenin mutant HCT 116 xenograft model, but not in the β-catenin wild type A375 xenograft model, in response to daily administration of nonactin in vivo. Furthermore, we found that expression of an active mutant form of β-catenin induced a decrease in the glycolysis rate. Taken together, our results demonstrate that tumor cells with mutated β-catenin depend on mitochondrial oxidative phosphorylation for survival. Therefore, they undergo apoptosis in response to mitochondrial dysfunction following the addition of mitochondrial uncouplers, such as nonactin. These results suggest that targeting mitochondria is a potential chemotherapeutic strategy for tumor cells that harbor β-catenin mutations.
AuthorsYuki Shikata, Masaki Kiga, Yushi Futamura, Harumi Aono, Hiroyuki Inoue, Manabu Kawada, Hiroyuki Osada, Masaya Imoto
JournalCancer science (Cancer Sci) Vol. 108 Issue 4 Pg. 772-784 (Apr 2017) ISSN: 1349-7006 [Electronic] England
PMID28107588 (Publication Type: Journal Article)
Copyright© 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • Macrolides
  • Uncoupling Agents
  • beta Catenin
  • nonactin
Topics
  • A549 Cells
  • Animals
  • Apoptosis (drug effects, genetics)
  • Blotting, Western
  • Carcinoma, Hepatocellular (drug therapy, genetics, pathology)
  • Cell Line, Tumor
  • Flow Cytometry
  • Glycolysis (drug effects, genetics)
  • HCT116 Cells
  • HT29 Cells
  • Humans
  • Liver Neoplasms (drug therapy, genetics, pathology)
  • Macrolides (chemistry, pharmacology)
  • Membrane Potential, Mitochondrial (drug effects)
  • Mitochondria (drug effects, metabolism)
  • Molecular Structure
  • Mutation
  • Uncoupling Agents (pharmacology)
  • Xenograft Model Antitumor Assays
  • beta Catenin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: